
CAS Number624-49-7
SynonymsDimethyl fumarate; EINECS 210-849-0; MFCD00064438
Molecular FormulaCH3OCOCH=CHCOOCH3
Molecular Weight144.13
Purity97%
Density1.1±0.1 g/cm3
Boiling Point192-193 °C (lit.)
Melting Point102-106 °C (lit.)
Appearancesolid
EINECS210-849-0
Symbol
Signal WordWarning
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 624-49-7 |
| Catalog No. | 2A-9024457 |
| Chinese Name | 富马酸二甲酯 |
| Synonyms | Dimethyl fumarate; EINECS 210-849-0; MFCD00064438 |
| Molecular Formula | CH3OCOCH=CHCOOCH3 |
| Molecular Weight | 144.13 |
| Purity | 97 |
| Density | 1.1±0.1 g/cm3 |
| Boiling Point | 192-193 °C (lit.) |
| Melting Point | 102-106 °C (lit.) |
| Appearance | solid |
| Storage Condition | Store in an airtight container in a cool, dry plac |
| Application | Dimethyl fumarate is an Nrf2 activator that can induce up-regulation of antioxidant gene expression. |
| EINECS | 210-849-0 |
| HTC | 2917140000 |
| PubChem ID | 24854591 |
| MDL Number | MFCD00064438 |
| SMILES | [H]\C(=C(\[H])C(=O)OC)C(=O)OC |
| InChI | 1S/C6H8O4/c1-9-5(7)3-4-6(8)10-2/h3-4H,1-2H3/b4-3+ |
| InChI Key | LDCRTTXIJACKKU-ONEGZZNKSA-N |
| Beilstein/REAXYS | 774590 |
| NACRES Code | NA.22 |
| UNSPSC | 12352100 |
| Hazard Symbols | transportation |
| MSDS | msds/24457_1_624_49_7.pdf |
| Bioactivity | Dimethyl fumarate is a nuclear factor (erythroid-derived)-like 2 (Nrf2) pathway activator and induces upregulation of antioxidant gene expression. Related Catalog Signaling Pathways >> NF-κB >> Keap1-Nrf2 Research Areas >> Inflammation/Immunology In Vitro Dimethyl fumarate causes short-lived oxidative stress, which leads to increased levels and nuclear localization of the transcription factor nuclear factor erythroid 2-related factor 2 and a subsequent increase in glutathione synthesis and recycling in neuronal cells[1]. Dimethyl fumarate inhibits dendritic cell (DC) maturation by reducing inflammatory cytokine production (IL-12 and IL-6) and the expression of MHC class II, CD80, and CD86. Dimethyl fumarate impairs nuclear factor κB (NF-κB) signaling via reduced p65 nuclear translocalization and phosphorylation. Dimethyl fumarate inhibits maturation of DCs and subsequently Th1 and Th17 cell differentiation by suppression of both NF-κB and ERK1/2-MSK1 signaling[2]. Dimethyl fumarate inhibits TNF-alpha-induced nuclear entry of NF-kappaB in rat heart endothelial cells (RHEC)[3]. Dimethyl fumarate, an immune modulator and inducer of the antioxidant response, suppresses HIV replication and neurotoxin release. Dimethyl fumarate attenuates CCL2-induced monocyte chemotaxis, suggesting that Dimethyl fumarate could decrease recruitment of activated monocytes to the CNS in response to inflammatory mediators[4]. In Vivo Dimethyl fumarate inhibits nuclear entry of NF-kappaB in RHEC and reduces myocardial infarct size after ischemia and reperfusion in rats in vivo[3]. Dimethyl fumarate oral administration is shown to upregulate mRNA and protein levels of Nrf2 and Nrf2-regulated cytoprotective genes, attenuate 6-OHDA induced striatal oxidative stress and inflammation in C57BL/6 mice[5]. Animal Admin In a blinded design, the rats are assigned to one of the three experimental groups: a) to the DMF group receiving 10 mg/kg body weight DMF (dissolved in DMSO 2% in water), or b) to the vehicle group receiving only the vehicle (DMSO 2% in water; necessary to dissolve DMF), or c) to the positive control group receiving the vehicle plus ischemic preconditioning (IPC, known to reduce infarct size). This dose of 10 mg/kg body weight of DMF corresponded approximately to a maximally tolerated dose in man. As we could confirm in our in vitro experiments that DMF is the active compound, the in vivo experiments are performed with DMF but not with MHF. DMF and the vehicle, respectively, tail vein is administrated by i.v. 90 min before ischemia (under general anesthesia using isoflurane) as well as immediately before ischemia. Ischemic preconditioning is induced by two times 5 min episodes ischemia (induced by left coronary artery occlusion) each followed by 5 min of reperfusion (induced by releasing the snare). The experiments are performed (except pilot experiments) pair wise, i.e. two experiments in parallel avoiding identical group assignment. The present study are set up, and permitted to demonstrate a pharmacodynamic effect of DMF on myocardial infarct size in rats in vivo. An eventual mode of action should be investigated in vitro. The results from our in vitro experiments as well as results of other laboratories did not show any effect of MHF on NF-κB activation. Therefore, no experiment is included to exclude MHF from the mode of action of DMF. References [1]. Albrecht P, et al. Effects of dimethyl fumarate on neuroprotection and immunomodulation. J Neuroinflammation. 2012 Jul 7;9:163 [2]. Peng H, et al. Dimethyl fumarate inhibits dendritic cell maturation via nuclear factor κB (NF-κB) and extracellular signal-regulated kinase 1 and 2 (ERK1/2) and mitogen stress-activated kinase 1 (MSK1) signaling. J Biol Chem. 2012 Aug 10;287(33):28017-26. [3]. Meili-Butz S, et al. Dimethyl fumarate, a small molecule drug for psoriasis, inhibits Nuclear Factor-kappaB and reduces myocardial infarct size in rats. Eur J Pharmacol. 2008 May 31;586(1-3):251-8. [4]. Cross SA, et al. Dimethyl fumarate, an immune modulator and inducer of the antioxidant response, suppresses HIV replication and macrophage-mediated neurotoxicity: a novel candidate for HIV neuroprotection. J Immunol. 2011 Nov 15;187(10):5015-25. [5]. Jing X, et al. Dimethyl fumarate attenuates 6-OHDA-induced neurotoxicity in SH-SY5Y cells and in animal model of Parkinson's disease by enhancing Nrf2 activity. Neuroscience. 2015 Feb 12;286:131-40 [6]. Li Y, et al. Dimethyl fumarate accelerates wound healing under diabetic condition. J Mol Endocrinol. 2018 Jul 23. pii: JME-18-0102. Chemical & Physical Properties Density 1.1±0.1 g/cm3 Boiling Point 193.0±0.0 °C at 760 mmHg Melting Point 102-106 °C(lit.) Molecular Formula C6H8O4 Molecular Weight 144.125 Flash Point 91.1±0.0 °C Exact Mass 144.042252 PSA 52.60000 LogP 0.62 Vapour Pressure 0.5±0.3 mmHg at 25°C Index of Refraction 1.435 InChIKey LDCRTTXIJACKKU-ONEGZZNKSA-N SMILES COC(=O)C=CC(=O)OC Storage condition Store at RT. Stability Stable. Incompatible with acids, bases, oxidizing agents, reducing agents. |
| Use of | Dimethyl fumarate is a nuclear factor (erythroid-derived)-like 2 (Nrf2) pathway activator and induces upregulation of antioxidant gene expression. Properties Articles25 Name dimethyl fumarate Synonym More Synonyms Dimethyl fumarate Biological Activity Description Dimethyl fumarate is a nuclear factor (erythroid-derived)-like 2 (Nrf2) pathway activator and induces upregulation of antioxidant gene expression. Related Catalog Signaling Pathways >> NF-κB >> Keap1-Nrf2 Research Areas >> Inflammation/Immunology References [1]. Albrecht P, et al. Effects of dimethyl fumarate on neuroprotection and immunomodulation. J Neuroinflammation. 2012 Jul 7;9:163 [3]. Meili-Butz S, et al. Dimethyl fumarate, a small molecule drug for psoriasis, inhibits Nuclear Factor-kappaB and reduces myocardial infarct size in rats. Eur J Pharmacol. 2008 May 31;586(1-3):251-8. [4]. Cross SA, et al. Dimethyl fumarate, an immune modulator and inducer of the antioxidant response, suppresses HIV replication and macrophage-mediated neurotoxicity: a novel candidate for HIV neuroprotection. J Immunol. 2011 Nov 15;187(10):5015-25. [5]. Jing X, et al. Dimethyl fumarate attenuates 6-OHDA-induced neurotoxicity in SH-SY5Y cells and in animal model of Parkinson's disease by enhancing Nrf2 activity. Neuroscience. 2015 Feb 12;286:131-40 [6]. Li Y, et al. Dimethyl fumarate accelerates wound healing under diabetic condition. J Mol Endocrinol. 2018 Jul 23. pii: JME-18-0102. Chemical & Physical Properties Molecular Formula C6H8O4 Exact Mass 144.042252 PSA 52.60000 Index of Refraction 1.435 InChIKey LDCRTTXIJACKKU-ONEGZZNKSA-N SMILES COC(=O)C=CC(=O)OC Storage condition Store at RT. Stability Stable. Incompatible with acids, bases, oxidizing agents, reducing agents. |
| Tax Rebate | 9.0% |
| Supervision | None MFN tariff: 6.5% Ordinary tariff: 30.0% |
| Transport Info | Shipping Name: UN |
| MSDS Transport Info | Module 14. Shipping information 14.1 UN dangerous goods number European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.2 United Nations shipping name European Land Transport Dangerous Regulations: Non-dangerous goods IMDG Code: Non-dangerous goods International air transport dangerous goods regulations: non-dangerous goods 14.3 Transport hazard categories European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.4 Package group European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.5 Environmental hazards European Land Transport Danger Regulations: No International Maritime Danger Regulations International Air Transport Danger Regulations: No Marine pollutants (yes/no): No 14.6 Special reminder to users No data available |
| Related Products in Specialty Chemicals | ||
|---|---|---|
| 9-Heptadecanol | 624-08-8 | 2A-9024448 |
| Propyl octanoate | 624-13-5 | 2A-9024449 |
| 1,4-Diaminobenzene dihydrochloride | 624-18-0 | 2A-9024450 |
| 2-Methylbutyl acetate | 624-41-9 | 2A-9024454 |
| Methyl levulinate | 624-45-3 | 2A-9024455 |
| N-Methylethylamine hydrochloride | 624-60-2 | 2A-9024458 |
| Iodoacetonitrile | 624-75-9 | 2A-9024460 |
| N-Ethylmethylamine | 624-78-2 | 2A-9024462 |
| Formylhydrazine | 624-84-0 | 2A-9024464 |
| Methylthioethane | 624-89-5 | 2A-9024465 |
| Browse all Specialty Chemicals products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA